William Harris Investors’s PANACOS PHARMACEUTICALS, INC. PANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$0 Hold
25,000
﹤0.01% 115
2016
Q3
$0 Hold
25,000
﹤0.01% 101
2016
Q2
$0 Hold
25,000
﹤0.01% 102
2016
Q1
$0 Hold
25,000
﹤0.01% 97
2015
Q4
$0 Hold
25,000
﹤0.01% 97
2015
Q3
$0 Hold
25,000
﹤0.01% 96
2015
Q2
$0 Hold
25,000
﹤0.01% 94
2015
Q1
$0 Hold
25,000
﹤0.01% 93
2014
Q4
$0 Hold
25,000
﹤0.01% 87
2014
Q3
$0 Hold
25,000
﹤0.01% 88
2014
Q2
$0 Hold
25,000
﹤0.01% 92
2014
Q1
$0 Hold
25,000
﹤0.01% 91
2013
Q4
$0 Hold
25,000
﹤0.01% 101
2013
Q3
$0 Hold
25,000
﹤0.01% 101
2013
Q2
$0 Buy
+25,000
New ﹤0.01% 91

William Harris Investors's PANC Position: Q4 2016 in Review

William Harris Investors held its PANACOS PHARMACEUTICALS, INC. (PANC) position steady in Q4 2016 at 25,000 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #115.

William Harris Investors first reported a position in PANC in Q2 2013 and has held it in 15 quarters since. 1 fund tracked by Wall St. Rank holds PANC as of Q4 2016.

  • William Harris Investors held 25,000 shares of PANACOS PHARMACEUTICALS, INC. worth $0 as of Q4 2016.
  • William Harris Investors left its PANACOS PHARMACEUTICALS, INC. share count unchanged in Q4 2016.
  • PANACOS PHARMACEUTICALS, INC. made up ﹤0.01% of William Harris Investors's portfolio in Q4 2016, its #115 holding.
  • William Harris Investors first reported a position in PANACOS PHARMACEUTICALS, INC. in Q2 2013 and has held it in 15 quarters since.
  • 1 fund tracked by Wall St. Rank held PANACOS PHARMACEUTICALS, INC. as of Q4 2016.

Based on William Harris Investors's 13F filing for Q4 2016, filed 7 Feb 2017.